Education
About Us
Working with TipRanks
Follow Us
Crescent Biopharma (CBIO)
NASDAQ:CBIO
| Dec 24 | Dec 23 | Dec 22 | Dec 21 | Dec 20 | |
|---|---|---|---|---|---|
| Income Statement | |||||
| Total Revenue | $ 0.00 | $ 10.00K | $ 75.00K | $ 1.16M | $ 10.16M |
| Gross Profit | $ 0.00 | $ 10.00K | $ 75.00K | $ 1.16M | $ 10.16M |
| Operating Income | $ -68.76M | $ -39.28M | $ -47.40M | $ -63.45M | $ -51.51M |
| EBITDA | $ 0.00 | $ -39.12M | $ -47.20M | $ -63.18M | $ -51.24M |
| Net Income | $ -71.47M | $ -36.90M | $ -46.69M | $ -63.43M | $ -51.03M |
| Balance Sheet | |||||
| Cash & Short-Term Investments | $ 34.77M | $ 41.79M | $ 47.87M | $ 90.25M | $ 137.04M |
| Total Assets | $ 35.62M | $ 45.32M | $ 51.81M | $ 94.35M | $ 142.83M |
| Total Debt | $ 37.48M | $ 808.40K | $ 918.55K | $ 1.92M | $ 2.82M |
| Net Debt | $ 2.72M | $ -40.98M | $ -46.95M | $ -88.33M | $ -134.22M |
| Total Liabilities | $ 51.10M | $ 6.90M | $ 8.88M | $ 12.74M | $ 14.61M |
| Stockholders' Equity | $ -15.48M | $ 38.41M | $ 42.93M | $ 81.60M | $ 128.22M |
| Cash Flow | |||||
| Free Cash Flow | $ -31.11M | $ -34.90M | $ -46.54M | $ -57.50M | $ -39.31M |
| Operating Cash Flow | $ -31.10M | $ -34.88M | $ -46.46M | $ -57.49M | $ -39.24M |
| Investing Cash Flow | $ 20.03K | $ -21.39K | $ -84.19K | $ -14.94K | $ -68.51K |
| Financing Cash Flow | $ 5.40K | $ 28.82M | $ 4.16M | $ 10.72M | $ 18.14M |